A Project to Test the Efficacy and Safety of An Innovative Treatment for Opiate Use Disorders.

Description

Investigators will test, for safety and efficacy, a novel treatment for opiate addiction that applies a 4-minute treatment of intense near infra-red light to stimulate a side of the brain that the investigators determine to be healthier, more mature, and less traumatized. Investigators will compare among actively using participants an active and a sham treatment given either once or twice weekly for 25-weeks at 2 sites. Investigators hope this will lead to a significant weapon in the battle against the opioid epidemic as well as lead to psychological and physiological insights into possible relations among trauma, cerebral laterality, and addiction.

Conditions

Opioid Use Disorder, Moderate, Opioid Use, Opioid Dependence, Opioid Abuse, Opiate Dependence, Opioid Use, Unspecified

Study Overview

Study Details

Study overview

Investigators will test, for safety and efficacy, a novel treatment for opiate addiction that applies a 4-minute treatment of intense near infra-red light to stimulate a side of the brain that the investigators determine to be healthier, more mature, and less traumatized. Investigators will compare among actively using participants an active and a sham treatment given either once or twice weekly for 25-weeks at 2 sites. Investigators hope this will lead to a significant weapon in the battle against the opioid epidemic as well as lead to psychological and physiological insights into possible relations among trauma, cerebral laterality, and addiction.

A Project to Test the Efficacy and Safety of An Innovative Treatment for Opiate Use Disorders.

A Project to Test the Efficacy and Safety of An Innovative Treatment for Opiate Use Disorders.

Condition
Opioid Use Disorder, Moderate
Intervention / Treatment

-

Contacts and Locations

Newton Highlands

MindLight, LLC, Newton Highlands, Massachusetts, United States, 02461

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Male or non-pregnant females between 18-65 years of age
  • * Individuals having an opioid use disorder with mild-to-moderately severe symptoms
  • * Individuals who are pregnant,
  • * Individuals who are psychotic,
  • * Individuals who are actively suicidal,
  • * Individuals who are a danger to self or others,
  • * Individuals who are who have a history of severe psychiatric or neurological disorders or life-threatening medical illness.
  • * Individuals will be excluded with chronic pain requiring opioid treatment.
  • * Individuals who are who are breastfeeding,
  • * Individuals who are adults requiring a legally authorized representative.

Ages Eligible for Study

18 Years to 65 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

MindLight, LLC,

Study Record Dates

2024-08-30